NCT06118125

Brief Summary

Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
376

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 25, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

3.3 years

First QC Date

October 25, 2023

Last Update Submit

November 1, 2023

Conditions

Keywords

digestive cancer, covid

Outcome Measures

Primary Outcomes (1)

  • time from date of first symptoms of cancer to the date of first MDT

    time from date of first symptoms of cancer to the date of first MDT

    DAYS

Secondary Outcomes (6)

  • time from date of first symptoms to date of first consultation with a general practitioner,

    DAYS

  • time from date of first symptoms to first imaging or specific examination,

    DAYS

  • time from date of first symptoms to consultation with a specialist,

    DAYS

  • stage of pathology by type of cancer,

    at inclusion

  • frequency of different types of cancer,

    at inclusion

  • +1 more secondary outcomes

Study Arms (2)

2019

patients diagnosed in 2019

2020

patients diagnosed in 2020

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male and female under 18 years old * residing in New Aquitaine and * whose general practitioner practiced in New Aquitaine * malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas. * to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

You may qualify if:

  • residing in New Aquitaine and
  • whose general practitioner practiced in New Aquitaine
  • malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas.
  • to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

You may not qualify if:

  • Patients under 18 years of age,
  • who had already had a MDT for this cancer,
  • whose new cancer was a digestive metastasis of a primary of another location,
  • who did not have French health insurance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blanc-Bisson Christele

Bordeaux, 33076, France

Location

MeSH Terms

Conditions

Colorectal NeoplasmsCOVID-19Liver NeoplasmsPancreatic NeoplasmsDiseaseGastrointestinal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesLiver DiseasesEndocrine Gland NeoplasmsPancreatic DiseasesEndocrine System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 25, 2023

First Posted

November 7, 2023

Study Start

June 1, 2019

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

November 7, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations